CuraToken
CuraToken
Token: CTKN


Improving Healthcare, Reducing Costs, Saving Lives Dedicated to reducing drug non-adherence while lowering healthcare costs and advancing medical research

PreICO dates
Start date: 2018-06-01
End date: 2018-06-08

ICO dates
Start date: 2018-06-08
End date: 2018-09-08

Registrated in: UK

Platform: Ethereum
Type: ERC20

PREMIUM ICO

HARA

Empowering billions by utilizing a global and transparent data exchange.
Ends in 114 days 19 hours
Goal: 17,000,000 USD
Price: 1 HART = 0.059 USD

Dominium

Dominium Blockchain – The one-stop-platform for everything to do with property anywhere in the world!
Ends in 83 days 19 hours
Goal: 17,500,000 USD
Price: 1 DOM = 0.25 EUR
CuraToken categories
Big Data Health
CuraToken whitepaper
Video
CuraToken token sale
KYC passing required Yes | Whitelist Yes | Restriction for countries USA
Soft cap $1M
Hard cap 25,000,000 USD
Tokens for sale 250,000,000
Token distribution in ICO
50%
50%
Price 1 CTKN = 0.20 USD
Price in PreICO $0.20
Acceppting ETH
Bonus in ICO contact us for larger investment sizes
We’re solving an enormous real-world problem by helping patients take their medications properly

Every day, millions of people fail to take their medications as prescribed and the resulting personal and financial costs are staggering. Worldwide, non-adherence results in $700 billion in avoidable medical costs.

The data we create is unique and has enormous value to pharmaceutical companies, researchers and governments.

Every time a patient uses our CuraServe technology, our data grows in utility and value.

Curaizon™ solves drug non-adherence problem by deploying our technology through national health services. As part of our solution, we collect fully anonymized data about how and when patients take medications.

CuraTokens™ are the only way to access our data. Tokens can be redeemed to access the data, which will advance medical research, drive down healthcare costs and save lives.

The value of a CuraToken™ is based on a real solution to a real problem.

CuraToken news, social
CuraToken search trends in Google
Random whitepaper excerpts

Contents
Legal Disclaimer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Drug Non-Adherence – A Global Problem. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Curaizon™. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
CuraData™ - Big Data For Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Why Is Our Medical Data So Valuable?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Real World Examples . . . . . . . . . . . . . . . . . . . . . . . ...

Legal Disclaimer
PLEASE REVIEW CAREFULLY THE PRESENT SECTION “LEGAL DISCLAIMER”. IF YOU HAVE ANY DOUBTS AS TO
WHAT ACTIONS YOU SHOULD TAKE, WE RECOMMEND THAT YOU CONSULT WITH YOUR LEGAL, FINANCIAL,
TAX OR OTHER PROFESSIONAL ADVISOR(S).
No part of this White Paper is to be reproduced, distributed or
disseminated without including this section “Legal Disclaimer”.
The sole purpose of this White Paper is to present Curaizon™ and CTKN tokens to potential token holders
in connection with the proposed token sale. This White Paper is provided for information purposes only. It
may not be exhaustive, it is not binding for Curaizon™, and does not imply any elements of a contractual
relationship or obligations. Despite the fact that we make every effort to ensure the accuracy, up to date
and relevance of any material in this White Paper, this document and materials contained herein are not
professional advice and in no way constitutes the provision of professional advice of any kind. Further,
Cura...

CTKN tokens are not and will not be intended to constitute securities, digital currency, commodity, or any other
kind of financial instrument and have not been registered under relevant securities regulations, including the
securities laws of any jurisdiction in which a potential token holder is a resident. This White Paper is not a
prospectus or a proposal, and its purpose is not to serve as a securities offer or request for investments in
the form of securities in any jurisdiction. However, in spite of the above, legislation of certain jurisdictions
may, now or in future, recognize CTKN tokens as securities. Curaizon™ does not accept any liability for such
recognition and/or any legal and other consequences of such recognition for potential owners of CTKN
tokens, nor provide any opinions or advice regarding the acquisition, sale or other operations with CTKN
tokens, and the fact of the provision of this White Paper does not form the basis or should not be relied upon
in matters related to the conclusion of contract...

Drug Non-Adherence – A Global Problem
Medicines are our most cost‐effective health intervention and represent the first line of defense against
chronic and long-term conditions. Hundreds of millions of people take them every day. However, medicines
are only effective if used correctly. Whether it’s insulin to treat diabetes, a beta blocker to treat hypertension
or levothyroxine to treat thyroid disease, medicines help improve our quality of life, save money, and in many
cases, keep us alive.
Unfortunately, far too many people fail to take their medications properly (also called drug non-adherence) and
the resulting personal and financial costs are staggering. The World Health Organization stated,
“increasing
the effectiveness of adherence interventions may have a far greater impact on the health of the population
than any improvement in specific medical treatments.”
Despite a worldwide recognition of the seriousness of the issue, and global efforts to improve medication
adherence, there ...

Curaizon™
Curaizon™ is the only company that offers a complete healthcare ecosystem that supports patients by
reducing drug non-adherence. The ecosystem include CuraServe™, CuraData™ and CuraView™ and helps to
lower healthcare costs and advance medical research.
Curaserve™

Communicates with
patients using non-intrusive
reminders.

Enables family members to
support patients.Supports
healthcare providers with a
real-time view into patient
behavior.
Curaview™

Integrates with health
services legacy systems.
• Ensures that all patient data
is current.
• Provides real-time feedback
to electronic medical
record.
Curadata™

Collects unique and
valuable data.

Holds only demographic
and adherence data.
Patient identifiers held by
health service.

Available through
CuraToken™
4
...

CuraData™ - Big Data For Healthcare
The enormous amount of unique and valuable data we collect through CuraServe™ finds a home in CuraData™.
Our system merges the data we collect through our real-time compliance technologies with the patient’s own
data. This data is stored off-chain onto an AES 256 encrypted cloud in an appropriate geographic domain with
the blockchain storing pointers and rules on access and usage all of which becomes part of the CuraData™. It
can be accessed regardless of the health service or EMR used
Healthcare providers benefit from Big Data if they take a more holistic, patient-centered approach to value;
one that focuses equally on health-care spending and treatment outcomes. This is made possible through the
data and analytics of Curaizon’s™ data. By overlaying the adherence data CuraServe™ produces, we are able
to quantify efficacy and sustainability of each drug a patient takes on an individual basis. This information can
be used to create an optimum drug regimen and dr...

Why Is Our Medical Data So Valuable?
The total number of potential users of our platform include all of the patients covered by national health
services across the world. This is a total of 1.4 Billion patients and growing.
7
Because we collect multiple data
points on each patient every day, we rapidly build an overall picture of not only a patient’s adherence, but
also their behavior. By storing the various data points, including: additional visits to a doctor, hospitalizations,
biometrics and other healthcare provider interactions, we can model behavior using our AI and machine
learning systems. Curaizon™ further enhance this data by allowing our partners to add their own as part of
our reward program, which will enrich the utility and value of our data tools. Our offering allows healthcare
professionals and family members to know not only a patient’s current well-being, but also a view into their
likely future performance. With this information, healthcare providers can employ early intervention...

Real World Examples
Patient
John visits his doctor because he has recently lost weight, despite feeling hungry and thirsty. After having a
blood test, he learns that he has type-2 diabetes and needs to take insulin on a regular basis. As part of his
treatment, John is enrolled in CuraServe™.
Shortly after John leaves, he is sent a notification from CuraServe™ welcoming him to the service. John will
now receive a series of reminders to ensure he takes his medicines and he is also monitored to check on how
often he takes the medicines as prescribed.
CuraServe™ has a built-in safety net and can notify John’s partner, or another designated person if he fails
to take his medication. Each time John takes his medications as intended, we make a small donation to a
charity of John’s choosing. This is an incentive for John to engage with the service and stay healthy. This
adherence data is shared with John’s healthcare provider who is able to see his adherence rates in real-time,
to intervene bef...

CuraToken Roadmap

1
January 2016

CuraServe™ Development Begins.
2
June 2017

CuraServe™ Testing Underway.
3
February 2018

CuraServe™ Alpha Release Complete.
4
June 1st 2018

Token Presale Begins.
5
June 8th 2018

Token Public Sale Begins.
6
September 2018

CuraData™ Beta Release Complete.
7
January 2018

CuraServe™ Public Release.
8
May 2019

CuraData™ Platform Growth.
9
2020


Curadata™ 2.0 Release.
Nicholas James Rumble
Management Nicholas James Rumble Chief Executive Officer (CEO)

Chris Matey
Management Chris Matey Chief Financial Officer (CFO)

Darran Trute
Managment Darran Trute Chief Technology Officer (CTO)

Andrey Verbitsky
Advisor Andrey Verbitsky Tokenomics Expert

Luke Lerdal
Management Luke Lerdal Chief Data Officer (CDO)

Rory McCrea
Advisor Rory McCrea Chief Advisor

Sarah Chilvers
Clinical Advisor Sarah Chilvers Advisor

Andrey Verbitsky
Andrey Verbitsky
Tokenomics Expert